Oral combination therapy with a nucleoside polymerase inhibitor (RG7128) and danoprevir for chronic hepatitis C genotype 1 infection (INFORM-1): a randomised, double-blind, placebo-controlled, dose-escalation trial

DOI Web Site Web Site 5 Citations

Journal

  • The Lancet

    The Lancet 376 (9751), 1467-1475, 2010-10

    Elsevier BV

Citations (5)*help

See more

Report a problem

Back to top